.Pharmacolibrary.Drugs.ATC.R.R01AB07 .Pharmacolibrary.Drugs.ATC.R.R01AB07| name: | Oxymetazoline |
| ATC code: | R01AB07 | route: | intranasal |
| n-compartments | 1 |
Oxymetazoline is a direct-acting alpha-adrenergic agonist primarily used as a topical decongestant for temporary relief of nasal congestion due to colds, allergies, or sinusitis. It is commonly found in over-the-counter nasal spray products. Oxymetazoline is approved and widely used today for short-term relief.
Pharmacokinetic parameters for oxymetazoline after intranasal administration in healthy adult volunteers. No population-specific differences (sex, age, or disease conditions) were reported.
Cacek, AT, et al., & Gopalakrishnan, M (2017). Population Pharmacokinetics of an Intranasally Administered Combination of Oxymetazoline and Tetracaine in Healthy Volunteers. Journal of clinical pharmacology 57(2) 247–254. DOI:10.1002/jcph.799 PUBMED:https://pubmed.ncbi.nlm.nih.gov/27436060
Kaessner, N, et al., & Lahu, G (2012). Population pharmacokinetic meta-analysis of intranasal fentanyl spray as a means to enrich pharmacokinetic information for patients with cancer breakthrough pain. International journal of clinical pharmacology and therapeutics 50(9) 665–677. DOI:10.5414/CP201737 PUBMED:https://pubmed.ncbi.nlm.nih.gov/22784611
Cartabuke, RS, et al., & Tobias, JD (2019). Hemodynamic and pharmacokinetic analysis of oxymetazoline use during nasal surgery in children. The Laryngoscope 129(12) 2775–2781. DOI:10.1002/lary.27760 PUBMED:https://pubmed.ncbi.nlm.nih.gov/30786035